ANTIBODY-MEDIATED REJECTION OF THE KIDNEY AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (SPKT): ALEMTUZUMAB IS NOT SUPERIOR TO BASILIXIMAB AS INDUCTION TREATMENT: 88
暂无分享,去创建一个
Y. Becker | S. Knechtle | J. Pascual | A. Djamali | H. Sollinger | J. Pirsch | J. Torrealba | G. Leverson | J. Odorico | M. Samaniego